PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma

BACKGROUND: Cervical small cell neuroendocrine carcinoma (SCNC) is a rare and aggressive disease that lacks a standard treatment strategy or effective methods of targeted therapy. PD-L1 inhibitors for DNA mismatch repair system-deficient (dMMR) tumors and neurotrophin receptor tyrosine kinase (NTRK)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Longyun, Yang, Fan, Feng, Ting, Wu, Shafei, Li, Kaimi, Pang, Junyi, Shi, Xiaohua, Liang, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566736/
https://www.ncbi.nlm.nih.gov/pubmed/34745983
http://dx.doi.org/10.3389/fonc.2021.752453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566736/
https://www.ncbi.nlm.nih.gov/pubmed/34745983
http://dx.doi.org/10.3389/fonc.2021.752453

Ejemplares similares